TREATMENT OPTIONS IN ONCOLOGY:@0.084848:0.038601:0.493541:0.038601:0.493541:0.019343:0.084848:0.019343:0.010019:0.014276:0.012606:0.015487:0.010019:0.021613:0.012606:0.017404:0.010019:0.006515:0.020438:0.013923:0.010019:0.005315:0.020438:0.017404:0.011712:0.006515:0.005315:0.017404:0.006515:0.020438:0.017404:0.019121:0.020438:0.010866:0.020438:0.020508:0.013923
10:@0.023705:0.038809:0.044778:0.038809:0.044778:0.019212:0.023705:0.019212:0.010536:0.010536
HANDBOOK OF ONCOLOGY:@0.084848:0.970015:0.320957:0.970015:0.320957:0.956010:0.084848:0.956010:0.011682:0.012657:0.012657:0.012726:0.009818:0.014864:0.014864:0.010109:0.004738:0.014864:0.008296:0.004738:0.014864:0.012657:0.013906:0.014864:0.007902:0.014864:0.014915:0.010126
results in maximisation of the combination :@0.084848:0.096166:0.481086:0.096166:0.481086:0.080410:0.084848:0.080410:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.007466:0.005907:0.003848:0.011738:0.005907:0.018049:0.013143:0.009236:0.003848:0.018049:0.003848:0.007466:0.013143:0.006523:0.003848:0.012604:0.011738:0.005907:0.012604:0.006042:0.005898:0.006523:0.011738:0.012508:0.005898:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330
chemotherapy dose intensity. :@0.084848:0.112411:0.366923:0.112411:0.366923:0.096655:0.084848:0.096655:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.013181:0.012604:0.007466:0.012508:0.005330:0.003848:0.011738:0.006523:0.012508:0.011738:0.007466:0.003848:0.006523:0.010314:0.005330:0.005330
DURATION OF CHEMOTHERAPY :@0.084848:0.145214:0.404272:0.145214:0.404272:0.127398:0.084848:0.127398:0.014966:0.013683:0.012401:0.015822:0.008980:0.005987:0.017960:0.015822:0.005987:0.017960:0.010263:0.005987:0.016677:0.014539:0.011118:0.019242:0.017960:0.008980:0.014539:0.011118:0.012401:0.015822:0.011973:0.013256:0.005987
TREATMENT:@0.084848:0.162926:0.197309:0.162926:0.197309:0.145111:0.084848:0.145111:0.008980:0.012401:0.011118:0.015822:0.008980:0.019242:0.011118:0.015822:0.008980
Numerous  randomised trials for the adju-:@0.084848:0.180313:0.475777:0.180313:0.475777:0.164557:0.084848:0.164557:0.014239:0.011699:0.018049:0.012508:0.005703:0.012604:0.011699:0.007466:0.006889:0.006889:0.005792:0.013143:0.011738:0.013181:0.012604:0.018049:0.003848:0.007466:0.012508:0.013181:0.006889:0.006523:0.005792:0.003848:0.013143:0.003848:0.007466:0.006889:0.006042:0.012604:0.005792:0.006875:0.006523:0.011738:0.012508:0.006875:0.013143:0.013181:0.003906:0.011699:0.006388
vant treatment of breast and colorectal :@0.084848:0.196559:0.481074:0.196559:0.481074:0.180803:0.084848:0.180803:0.010660:0.013143:0.011738:0.006523:0.008948:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.008948:0.012604:0.006042:0.008948:0.013123:0.005715:0.012508:0.013143:0.007466:0.006523:0.008948:0.013143:0.011738:0.013181:0.008948:0.012450:0.012604:0.003848:0.012604:0.005707:0.012508:0.012450:0.006523:0.013143:0.003848:0.005330
cancer  have  confirmed  that  six  months :@0.084848:0.212804:0.481096:0.212804:0.481096:0.197048:0.084848:0.197048:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.005330:0.005059:0.011738:0.013143:0.010660:0.012508:0.005330:0.005068:0.012450:0.012604:0.011738:0.004686:0.004686:0.006313:0.018049:0.012508:0.013181:0.005330:0.005067:0.006523:0.011738:0.013143:0.006523:0.005330:0.005061:0.007466:0.003848:0.009236:0.005330:0.005074:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.005330
is as effective as 12 months  of chemo- :@0.084848:0.229049:0.481088:0.229049:0.481088:0.213294:0.084848:0.213294:0.003848:0.007466:0.010487:0.013143:0.007466:0.010487:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.003848:0.010660:0.012508:0.010487:0.013143:0.007466:0.010487:0.010660:0.010660:0.010487:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.005330:0.005147:0.012604:0.006042:0.010487:0.012450:0.011738:0.012508:0.018049:0.012604:0.006402:0.005330
therapy treatment.  Ongoing studies are :@0.084848:0.245295:0.481101:0.245295:0.481101:0.229539:0.084848:0.229539:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.010660:0.006523:0.005711:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.005330:0.005319:0.016722:0.011738:0.012950:0.012604:0.003848:0.011738:0.012941:0.010660:0.007466:0.006523:0.011699:0.013181:0.003848:0.012508:0.007466:0.010660:0.013143:0.005715:0.012508:0.005330
going to determine whether three months :@0.084848:0.261540:0.481111:0.261540:0.481111:0.245784:0.084848:0.245784:0.012950:0.012604:0.003848:0.011738:0.012950:0.005330:0.006523:0.012604:0.005330:0.013181:0.012508:0.006523:0.012508:0.006319:0.018049:0.003848:0.011738:0.012508:0.005330:0.015990:0.011738:0.012508:0.006523:0.011738:0.012508:0.005792:0.005315:0.006523:0.011738:0.005707:0.012508:0.012508:0.005330:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.005330
of  adjuvant chemotherapy  will yield the :@0.084848:0.277786:0.481080:0.277786:0.481080:0.262030:0.084848:0.262030:0.012604:0.006042:0.005330:0.003820:0.013143:0.013181:0.003906:0.011699:0.010660:0.013143:0.011738:0.006523:0.009159:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.003812:0.015990:0.003848:0.003848:0.003848:0.009159:0.010314:0.003848:0.012508:0.003848:0.013181:0.009159:0.006523:0.011738:0.012508:0.005330
same level of clinical benefit as six months :@0.084848:0.294031:0.481094:0.294031:0.481094:0.278275:0.084848:0.278275:0.007466:0.013143:0.018049:0.012508:0.005359:0.003848:0.012508:0.010660:0.012508:0.003848:0.005361:0.012604:0.006042:0.005351:0.012450:0.003848:0.003848:0.011738:0.003848:0.012450:0.013143:0.003848:0.005369:0.013123:0.012508:0.011738:0.012508:0.004686:0.004686:0.006523:0.005346:0.013143:0.007466:0.005361:0.007466:0.003848:0.009236:0.005363:0.018049:0.012604:0.011738:0.006523:0.011738:0.007466:0.005330
of treatment of early-stage colon cancer.:@0.084848:0.310277:0.463343:0.310277:0.463343:0.294521:0.084848:0.294521:0.012604:0.006042:0.003637:0.006523:0.005709:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.003623:0.012604:0.006042:0.003637:0.012508:0.013143:0.005792:0.003848:0.010314:0.006388:0.007466:0.006523:0.013143:0.012950:0.012508:0.003637:0.012450:0.012604:0.003848:0.012604:0.011738:0.003625:0.012450:0.013143:0.011738:0.012450:0.012508:0.004376:0.005330
19:@0.463323:0.304627:0.475753:0.304627:0.475753:0.295441:0.463323:0.295441:0.006215:0.006215
The potential risk of cumulative adverse :@0.103030:0.326487:0.481122:0.326487:0.481122:0.310731:0.103030:0.310731:0.007812:0.011353:0.012123:0.008890:0.012738:0.012219:0.006138:0.012123:0.011353:0.006138:0.003464:0.012758:0.003464:0.008890:0.005407:0.003464:0.007081:0.009275:0.008890:0.012219:0.005657:0.008890:0.012065:0.011315:0.017665:0.011315:0.003464:0.012758:0.006138:0.003464:0.010275:0.012123:0.008890:0.012758:0.012796:0.010275:0.012123:0.005407:0.007081:0.012506:0.005330
effects, such as anthracycline-related car-:@0.084846:0.342733:0.475788:0.342733:0.475788:0.326977:0.084846:0.326977:0.012123:0.005713:0.005657:0.012123:0.012065:0.006138:0.007081:0.004945:0.007966:0.007081:0.011315:0.012065:0.011353:0.007966:0.012758:0.007081:0.007966:0.012758:0.011353:0.006138:0.011353:0.005407:0.012758:0.012065:0.009929:0.012065:0.003464:0.003464:0.011353:0.012123:0.006004:0.005326:0.012123:0.003464:0.012758:0.006138:0.012123:0.012796:0.007966:0.012065:0.012758:0.005407:0.006388
diotoxicity and taxane and/or platinum :@0.084846:0.358978:0.481067:0.358978:0.481067:0.343222:0.084846:0.343222:0.012796:0.003464:0.012219:0.006138:0.012219:0.008852:0.003464:0.012065:0.003464:0.006138:0.009929:0.014355:0.012758:0.011353:0.012796:0.014355:0.006138:0.012758:0.008852:0.012758:0.011353:0.012123:0.014355:0.012758:0.011353:0.012796:0.008024:0.012219:0.005407:0.014355:0.012738:0.003464:0.012758:0.006138:0.003464:0.011353:0.011315:0.018049:0.005330
neurotoxicity must always be factored into :@0.084846:0.375223:0.481095:0.375223:0.481095:0.359467:0.084846:0.359467:0.011353:0.012123:0.011315:0.005328:0.012219:0.006138:0.012219:0.008852:0.003464:0.012065:0.003464:0.006138:0.009929:0.007004:0.017665:0.011315:0.007081:0.006138:0.007004:0.012758:0.003464:0.015606:0.012758:0.009929:0.007081:0.007004:0.012738:0.012123:0.007004:0.005657:0.012758:0.012065:0.006138:0.012219:0.005326:0.012123:0.012796:0.007004:0.003464:0.011353:0.006138:0.012600:0.005330
the decision-making process. Addition-:@0.084846:0.391469:0.475771:0.391469:0.475771:0.375713:0.084846:0.375713:0.006138:0.011353:0.012123:0.019204:0.012796:0.012123:0.012065:0.003464:0.007081:0.003464:0.012219:0.011353:0.006004:0.017665:0.012758:0.009275:0.003464:0.011353:0.012565:0.019204:0.012738:0.005326:0.012219:0.012065:0.012123:0.007081:0.007081:0.004945:0.019204:0.013855:0.012796:0.012796:0.003464:0.006138:0.003464:0.012219:0.011353:0.006388
ally, there is no evidence that chemother-:@0.084846:0.407714:0.475781:0.407714:0.475781:0.391958:0.084846:0.391958:0.012758:0.003464:0.003464:0.009929:0.004945:0.007608:0.006138:0.011353:0.012123:0.005328:0.012123:0.007608:0.003464:0.007081:0.007608:0.011353:0.012219:0.007608:0.012123:0.010275:0.003464:0.012796:0.012123:0.011353:0.012065:0.012123:0.007608:0.006138:0.011353:0.012758:0.006138:0.007608:0.012065:0.011353:0.012123:0.017665:0.012219:0.006138:0.011353:0.012123:0.005407:0.006388
apy treatment is of clinical benefit in con-:@0.084846:0.423960:0.475759:0.423960:0.475759:0.408204:0.084846:0.408204:0.012758:0.012738:0.009929:0.007843:0.006138:0.005328:0.012123:0.012758:0.006138:0.017665:0.012123:0.011353:0.006138:0.007843:0.003464:0.007081:0.007843:0.012219:0.005657:0.007843:0.012065:0.003464:0.003464:0.011353:0.003464:0.012065:0.012758:0.003464:0.007845:0.012738:0.012123:0.011353:0.012123:0.004493:0.004493:0.006138:0.007843:0.003464:0.011353:0.007843:0.012065:0.012219:0.011353:0.006388
tinuing therapy until disease progression. A :@0.084846:0.440205:0.481086:0.440205:0.481086:0.424449:0.084846:0.424449:0.006138:0.003464:0.011353:0.011315:0.003464:0.011353:0.012565:0.007395:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.007395:0.011315:0.011353:0.006138:0.003464:0.003464:0.007395:0.012796:0.003464:0.007081:0.012123:0.012758:0.007081:0.012123:0.007395:0.012738:0.005328:0.012219:0.012565:0.005326:0.012123:0.007081:0.007081:0.003464:0.012219:0.011353:0.004945:0.007397:0.014234:0.005330
randomised clinical study in patients with :@0.084846:0.456450:0.481065:0.456450:0.481065:0.440695:0.084846:0.440695:0.005407:0.012758:0.011353:0.012796:0.012219:0.017665:0.003464:0.007081:0.012123:0.012796:0.010064:0.012065:0.003464:0.003464:0.011353:0.003464:0.012065:0.012758:0.003464:0.010064:0.007081:0.006138:0.011315:0.012796:0.009929:0.010064:0.003464:0.011353:0.010064:0.012738:0.012758:0.006138:0.003464:0.012123:0.011353:0.006138:0.007081:0.010064:0.015606:0.003464:0.006138:0.011736:0.005330
metastatic  CRC  comparing  continuous :@0.084846:0.472696:0.481107:0.472696:0.481107:0.456940:0.084846:0.456940:0.017665:0.012123:0.006138:0.012758:0.007081:0.006138:0.012758:0.006138:0.003464:0.012065:0.005330:0.012552:0.015259:0.011295:0.015259:0.005330:0.012552:0.012065:0.012219:0.017665:0.012738:0.012758:0.005407:0.003464:0.011353:0.012565:0.005330:0.012552:0.012065:0.012219:0.011353:0.006138:0.003464:0.011353:0.011315:0.012219:0.011315:0.007470:0.005330
and intermittent  palliative  chemotherapy :@0.084846:0.488941:0.481099:0.488941:0.481099:0.473185:0.084846:0.473185:0.012758:0.011353:0.012796:0.011699:0.003464:0.011353:0.006138:0.012123:0.005938:0.017665:0.003464:0.006138:0.006138:0.012123:0.011353:0.006138:0.005330:0.006360:0.012738:0.012758:0.003464:0.003464:0.003464:0.012758:0.006138:0.003464:0.010275:0.012123:0.005330:0.006360:0.012065:0.011353:0.012123:0.017665:0.012219:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.010316:0.005330
determined that a policy of drug holiday :@0.084846:0.505187:0.481120:0.505187:0.481120:0.489431:0.084846:0.489431:0.012796:0.012123:0.006138:0.012123:0.005940:0.017665:0.003464:0.011353:0.012123:0.012796:0.009179:0.006138:0.011353:0.012758:0.006138:0.009179:0.012758:0.009179:0.012738:0.012219:0.003464:0.003464:0.012065:0.009929:0.009179:0.012219:0.005657:0.009179:0.012796:0.005407:0.011315:0.012565:0.009179:0.011353:0.012219:0.003464:0.003464:0.012796:0.012758:0.010316:0.005330
and  re-challenging  with  the  same  agents :@0.084846:0.521432:0.481101:0.521432:0.481101:0.505676:0.084846:0.505676:0.012758:0.011353:0.012796:0.005330:0.003837:0.005328:0.012123:0.006004:0.012065:0.011353:0.012758:0.003464:0.003464:0.012123:0.011353:0.012565:0.003464:0.011353:0.012565:0.005330:0.003835:0.015606:0.003464:0.006138:0.011353:0.005330:0.003835:0.006138:0.011353:0.012123:0.005330:0.003837:0.007081:0.012758:0.017665:0.012123:0.005330:0.003835:0.012758:0.012565:0.012123:0.011353:0.006138:0.007470:0.005330
provides  a  reasonable  treatment  choice :@0.084846:0.537678:0.481086:0.537678:0.481086:0.521922:0.084846:0.521922:0.012738:0.005328:0.012219:0.010275:0.003464:0.012796:0.012123:0.007081:0.005330:0.006356:0.012758:0.005330:0.006358:0.005326:0.012123:0.012758:0.007081:0.012219:0.011353:0.012758:0.012738:0.003464:0.012123:0.005330:0.006358:0.006138:0.005328:0.012123:0.012758:0.006138:0.017665:0.012123:0.011353:0.006138:0.005330:0.006358:0.012065:0.011353:0.012219:0.003464:0.012065:0.012506:0.005330
for these patients. Similar observations have :@0.084846:0.553923:0.481122:0.553923:0.481122:0.538167:0.084846:0.538167:0.005657:0.012219:0.005407:0.005388:0.006138:0.011353:0.012123:0.007081:0.012123:0.005388:0.012738:0.012758:0.006138:0.003464:0.012123:0.011353:0.006138:0.007081:0.004945:0.005388:0.009198:0.003464:0.017665:0.003464:0.003464:0.012758:0.005407:0.005388:0.012219:0.012738:0.007081:0.012123:0.005407:0.010275:0.012758:0.006138:0.003464:0.012219:0.011353:0.007081:0.005388:0.011353:0.012758:0.010275:0.012506:0.005330
been reported in the treatment of metastat-:@0.084846:0.570168:0.475788:0.570168:0.475788:0.554412:0.084846:0.554412:0.012738:0.012123:0.012123:0.011353:0.004079:0.005326:0.012123:0.012738:0.012219:0.005407:0.006138:0.012123:0.012796:0.004079:0.003464:0.011353:0.004079:0.006138:0.011353:0.012123:0.004079:0.006138:0.005328:0.012123:0.012758:0.006138:0.017665:0.012123:0.011353:0.006138:0.004079:0.012219:0.005657:0.004079:0.017665:0.012123:0.006138:0.012758:0.007081:0.006138:0.012758:0.006138:0.006388
ic disease of other tumour types, including :@0.084846:0.586414:0.481120:0.586414:0.481120:0.570658:0.084846:0.570658:0.003464:0.012065:0.007274:0.012796:0.003464:0.007081:0.012123:0.012758:0.007081:0.012123:0.007274:0.012219:0.005657:0.007274:0.012219:0.006138:0.011353:0.012123:0.005407:0.007274:0.006138:0.011315:0.017665:0.012219:0.011315:0.005407:0.007274:0.006138:0.009929:0.012738:0.012123:0.007081:0.004945:0.007274:0.003464:0.011353:0.012065:0.003464:0.011315:0.012796:0.003464:0.011353:0.012946:0.005330
NSCLC, breast cancer, germ-cell cancer, :@0.084846:0.602659:0.481105:0.602659:0.481105:0.586903:0.084846:0.586903:0.013855:0.009198:0.015259:0.008505:0.015259:0.004945:0.011141:0.012738:0.005328:0.012123:0.012758:0.007081:0.006138:0.011141:0.012065:0.012758:0.011353:0.012065:0.012123:0.003383:0.004945:0.011141:0.012565:0.012123:0.005938:0.017665:0.006004:0.012065:0.012123:0.003464:0.003464:0.011141:0.012065:0.012758:0.011353:0.012065:0.012123:0.003383:0.005328:0.005330
ovarian cancer, and small-cell lung cancer.  :@0.084846:0.618905:0.481070:0.618905:0.481070:0.603149:0.084846:0.603149:0.012219:0.010275:0.012758:0.005407:0.003464:0.012758:0.011353:0.005426:0.012065:0.012758:0.011353:0.012065:0.012123:0.003383:0.004945:0.005426:0.012758:0.011353:0.012796:0.005426:0.007081:0.017665:0.012758:0.003464:0.003464:0.006004:0.012065:0.012123:0.003464:0.003464:0.005426:0.003464:0.011315:0.011353:0.012565:0.005426:0.012065:0.012758:0.011353:0.012065:0.012123:0.003993:0.005328:0.000000:0.005330
The two main problems associated with sys-:@0.084846:0.635150:0.475734:0.635150:0.475734:0.619394:0.084846:0.619394:0.007812:0.011353:0.012123:0.005253:0.006138:0.015606:0.012219:0.005253:0.017665:0.012758:0.003464:0.011353:0.005253:0.012738:0.005328:0.012219:0.012738:0.003464:0.012123:0.017665:0.007081:0.005253:0.012758:0.007081:0.007081:0.012219:0.012065:0.003464:0.012758:0.006138:0.012123:0.012796:0.005253:0.015606:0.003464:0.006138:0.011353:0.005253:0.007081:0.009929:0.007081:0.006388
temic cancer chemotherapy are the toxic-:@0.084846:0.651395:0.475788:0.651395:0.475788:0.635640:0.084846:0.635640:0.006138:0.012123:0.017665:0.003464:0.012065:0.005780:0.012065:0.012758:0.011353:0.012065:0.012123:0.005407:0.005780:0.012065:0.011353:0.012123:0.017665:0.012219:0.006138:0.011353:0.012123:0.005407:0.012758:0.012738:0.009929:0.005780:0.012758:0.005328:0.012123:0.005778:0.006138:0.011353:0.012123:0.005778:0.006138:0.012219:0.008852:0.003464:0.012065:0.006388
ity to the healthy body tissues and the de-:@0.084846:0.667641:0.475756:0.667641:0.475756:0.651885:0.084846:0.651885:0.003464:0.006138:0.009929:0.007062:0.006138:0.012219:0.007062:0.006138:0.011353:0.012123:0.007062:0.011353:0.012123:0.012758:0.003464:0.006138:0.011353:0.009929:0.007062:0.012738:0.012219:0.012796:0.009929:0.007062:0.006138:0.003464:0.007081:0.007081:0.011315:0.012123:0.007081:0.007062:0.012758:0.011353:0.012796:0.007062:0.006138:0.011353:0.012123:0.007062:0.012796:0.012123:0.006388
velopment of cellular drug resistance.  :@0.084846:0.683886:0.431471:0.683886:0.431471:0.668130:0.084846:0.668130:0.010275:0.012123:0.003464:0.012219:0.012738:0.017665:0.012123:0.011353:0.006138:0.004945:0.012219:0.005657:0.004945:0.012065:0.012123:0.003464:0.003464:0.011315:0.003464:0.012758:0.005407:0.004945:0.012796:0.005407:0.011315:0.012565:0.004945:0.005328:0.012123:0.007081:0.003464:0.007081:0.006138:0.012758:0.011353:0.012065:0.012123:0.005326:0.004559:0.005330
ADVERSE EFFECTS OF :@0.084848:0.716931:0.323796:0.716931:0.323796:0.697334:0.084848:0.697334:0.017404:0.016463:0.016463:0.012230:0.013641:0.012230:0.012230:0.006585:0.012230:0.011289:0.011289:0.012230:0.018344:0.009878:0.012230:0.006585:0.019756:0.011289:0.006585
CHEMOTHERAPY TREATMENT:@0.084848:0.736107:0.399526:0.736107:0.399526:0.716511:0.084848:0.716511:0.018344:0.015993:0.012230:0.021167:0.019756:0.009878:0.015993:0.012230:0.013641:0.017404:0.013170:0.014581:0.006585:0.009878:0.013641:0.012230:0.017404:0.009878:0.021167:0.012230:0.017404:0.009878
The most common side effects of chemo-:@0.084848:0.754647:0.475758:0.754647:0.475758:0.738891:0.084848:0.738891:0.008197:0.011738:0.012508:0.005888:0.018049:0.012604:0.007466:0.006523:0.005898:0.012450:0.012604:0.018049:0.018049:0.012604:0.011738:0.005890:0.007466:0.003848:0.013181:0.012508:0.005907:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.005907:0.012604:0.006042:0.005892:0.012450:0.011738:0.012508:0.018049:0.012573:0.006388
therapy are summarised in Table 4.:@0.084848:0.770892:0.408592:0.770892:0.408592:0.755136:0.084848:0.755136:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.013143:0.005707:0.012508:0.005330:0.007466:0.011699:0.018049:0.018049:0.013143:0.005792:0.003848:0.007466:0.012508:0.013181:0.005330:0.003848:0.011738:0.005330:0.007195:0.013143:0.013123:0.003848:0.012508:0.005330:0.010660:0.005330
IMMUNOSUPPRESSION  :@0.084848:0.803695:0.323005:0.803695:0.323005:0.785880:0.084848:0.785880:0.005987:0.019242:0.019242:0.013683:0.015822:0.017960:0.011118:0.013683:0.011973:0.011973:0.012401:0.011118:0.011118:0.011118:0.005987:0.017960:0.015822:0.005965:0.005987
AND MYELOSUPPRESSION:@0.084848:0.821407:0.342697:0.821407:0.342697:0.803592:0.084848:0.803592:0.015822:0.015822:0.014966:0.005987:0.019242:0.013256:0.011118:0.009407:0.017960:0.011118:0.013683:0.011973:0.011973:0.012401:0.011118:0.011118:0.011118:0.005987:0.017960:0.015822
Chemotherapy  agents have a broad :@0.084848:0.838795:0.481092:0.838795:0.481092:0.823039:0.084848:0.823039:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005330:0.010645:0.013143:0.012950:0.012508:0.011738:0.006523:0.007466:0.015990:0.011738:0.013143:0.010660:0.012508:0.015990:0.013143:0.015990:0.013123:0.005715:0.012604:0.013143:0.013181:0.005330
spectrum of side effects that depend on :@0.084848:0.855040:0.481121:0.855040:0.481121:0.839284:0.084848:0.839284:0.007466:0.013123:0.012508:0.012450:0.006523:0.005792:0.011699:0.018049:0.007589:0.012604:0.006042:0.007591:0.007466:0.003848:0.013181:0.012508:0.007601:0.012508:0.006096:0.006042:0.012508:0.012450:0.006523:0.007466:0.007601:0.006523:0.011738:0.013143:0.006523:0.007601:0.013181:0.012508:0.013123:0.012508:0.011738:0.013181:0.007601:0.012604:0.011738:0.005330
the type of drug, route of administration, :@0.084848:0.871285:0.481094:0.871285:0.481094:0.855529:0.084848:0.855529:0.006523:0.011738:0.012508:0.007601:0.006523:0.010314:0.013123:0.012508:0.007607:0.012604:0.006042:0.007605:0.013181:0.005792:0.011699:0.012950:0.005330:0.007603:0.005711:0.012604:0.011699:0.006523:0.012508:0.007597:0.012604:0.006042:0.007603:0.013143:0.013181:0.018049:0.003848:0.011738:0.003848:0.007466:0.006523:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.005330
and combination used. In general chemo-:@0.084848:0.887531:0.475758:0.887531:0.475758:0.871775:0.084848:0.871775:0.013143:0.011738:0.013181:0.004137:0.012450:0.012604:0.018049:0.013123:0.003848:0.011738:0.013143:0.006523:0.003848:0.012604:0.011738:0.004137:0.011699:0.007466:0.012508:0.013181:0.005330:0.004137:0.004349:0.011738:0.004137:0.012950:0.012508:0.011738:0.012508:0.005792:0.013143:0.003848:0.004137:0.012450:0.011738:0.012508:0.018049:0.012604:0.006388
therapy drugs affect rapidly-dividing cells, :@0.084848:0.903776:0.481092:0.903776:0.481092:0.888020:0.084848:0.888020:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.005388:0.013181:0.005792:0.011699:0.012950:0.007466:0.005388:0.013143:0.006098:0.006042:0.012508:0.012450:0.006523:0.005388:0.005792:0.013143:0.013123:0.003848:0.013181:0.003848:0.010314:0.006388:0.013195:0.003848:0.010660:0.003848:0.013181:0.003848:0.011738:0.012950:0.005399:0.012450:0.012508:0.003848:0.003848:0.007466:0.005330:0.005330
such as blood cells and the cells of the mu-:@0.084848:0.920022:0.475769:0.920022:0.475769:0.904266:0.084848:0.904266:0.007466:0.011699:0.012450:0.011738:0.004106:0.013143:0.007466:0.004118:0.013123:0.003848:0.012604:0.012604:0.013181:0.004106:0.012450:0.012508:0.003848:0.003848:0.007466:0.004118:0.013143:0.011738:0.013181:0.004106:0.006523:0.011738:0.012508:0.004101:0.012450:0.012508:0.003848:0.003848:0.007466:0.004118:0.012604:0.006042:0.004102:0.006523:0.011738:0.012508:0.004101:0.018049:0.011699:0.006388
cous membranes. Chemotherapy-related :@0.084848:0.936267:0.481092:0.936267:0.481092:0.920511:0.084848:0.920511:0.012450:0.012604:0.011699:0.007466:0.005753:0.018049:0.012508:0.018049:0.013123:0.005792:0.013143:0.011738:0.012508:0.007466:0.005330:0.005753:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012492:0.005792:0.013143:0.013123:0.010314:0.006388:0.005715:0.012508:0.003848:0.013143:0.006523:0.012508:0.013181:0.005330
toxicities can occur acutely after adminis-:@0.524249:0.640423:0.915158:0.640423:0.915158:0.624667:0.524249:0.624667:0.006523:0.012604:0.009236:0.003848:0.012450:0.003848:0.006523:0.003848:0.012508:0.007466:0.005523:0.012450:0.013143:0.011738:0.005513:0.012604:0.012450:0.012450:0.011699:0.005792:0.005505:0.013143:0.012450:0.011699:0.006523:0.012508:0.003848:0.010314:0.005523:0.013143:0.006042:0.006523:0.012508:0.005792:0.005509:0.013143:0.013181:0.018049:0.003848:0.011738:0.003848:0.007468:0.006388
tration, within hours or days, or chronically, :@0.524249:0.656854:0.920486:0.656854:0.920486:0.641098:0.524249:0.641098:0.006523:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.004853:0.015990:0.003848:0.006523:0.011738:0.003848:0.011738:0.004868:0.011738:0.012604:0.011699:0.005792:0.007466:0.004868:0.012604:0.005792:0.004859:0.013181:0.013143:0.010314:0.007466:0.005330:0.004868:0.012604:0.005782:0.004868:0.012450:0.011738:0.005709:0.012604:0.011738:0.003848:0.012450:0.013143:0.003848:0.003848:0.010314:0.005330:0.005330
from weeks to years. :@0.524249:0.673284:0.719786:0.673284:0.719786:0.657528:0.524249:0.657528:0.006042:0.005711:0.012604:0.018049:0.005330:0.015990:0.012508:0.012508:0.009660:0.007466:0.005330:0.006523:0.012604:0.005330:0.010314:0.012508:0.013143:0.005792:0.007466:0.005330:0.005330
Virtually all chemotherapeutic  regi-:@0.542433:0.689715:0.915150:0.689715:0.915150:0.673959:0.542433:0.673959:0.013604:0.003848:0.005792:0.006523:0.011699:0.013143:0.003848:0.003848:0.010314:0.020224:0.013143:0.003848:0.003848:0.020224:0.012450:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.012508:0.011699:0.006523:0.003848:0.012450:0.005330:0.014869:0.005713:0.012508:0.012950:0.003848:0.006388
mens can cause depression of the im-:@0.524249:0.706146:0.915158:0.706146:0.915158:0.690390:0.524249:0.690390:0.018049:0.012508:0.011738:0.007466:0.011449:0.012450:0.013143:0.011738:0.011449:0.012450:0.013143:0.011699:0.007466:0.012508:0.011449:0.013181:0.012508:0.013123:0.005715:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.011449:0.012604:0.006042:0.011449:0.006523:0.011738:0.012508:0.011449:0.003848:0.018049:0.006388
mune system, myelosuppression leading :@0.524249:0.722576:0.920473:0.722576:0.920473:0.706820:0.524249:0.706820:0.018049:0.011699:0.011738:0.012508:0.011315:0.007466:0.010314:0.007466:0.006523:0.012508:0.018049:0.005330:0.011315:0.018049:0.010314:0.012508:0.003848:0.012604:0.007466:0.011699:0.013123:0.013123:0.005719:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.011315:0.003848:0.012508:0.013143:0.013181:0.003848:0.011738:0.012950:0.005330
to leukopaenia, neutropaenia, anaemia, :@0.524249:0.739007:0.920496:0.739007:0.920496:0.723251:0.524249:0.723251:0.006523:0.012604:0.008043:0.003848:0.012508:0.011699:0.009660:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.008043:0.011738:0.012508:0.011699:0.006523:0.005703:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.008043:0.013143:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.005330
and thrombocytopaenia.  Anaemia and :@0.524249:0.755438:0.920509:0.755438:0.920509:0.739682:0.524249:0.739682:0.013143:0.011738:0.013181:0.011026:0.006523:0.011738:0.005707:0.012604:0.018049:0.013123:0.012604:0.012450:0.010314:0.006523:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.005330:0.005686:0.014239:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.011026:0.013143:0.011738:0.013181:0.005330
thrombocytopaenia, when they occur, :@0.524249:0.771868:0.920509:0.771868:0.920509:0.756112:0.524249:0.756112:0.006523:0.011738:0.005707:0.012604:0.018049:0.013123:0.012604:0.012450:0.010314:0.006523:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.014836:0.015990:0.011738:0.012508:0.011738:0.014836:0.006523:0.011738:0.012508:0.010314:0.014836:0.012604:0.012450:0.012450:0.011699:0.003762:0.005330:0.005330
are treated  with  blood transfusion.  Neu-:@0.524249:0.788299:0.915158:0.788299:0.915158:0.772543:0.524249:0.772543:0.013143:0.005715:0.012508:0.009563:0.006523:0.005709:0.012508:0.013143:0.006523:0.012508:0.013181:0.005330:0.004224:0.015990:0.003848:0.006523:0.011738:0.005330:0.004222:0.013123:0.003848:0.012604:0.012604:0.013181:0.009563:0.006523:0.005792:0.013143:0.011738:0.007466:0.006042:0.011699:0.007466:0.003848:0.012604:0.011738:0.005330:0.005330:0.004224:0.014239:0.012508:0.011678:0.006388
tropaenia (a decrease in the neutrophil :@0.524249:0.804729:0.920486:0.804729:0.920486:0.788973:0.524249:0.788973:0.006523:0.005709:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.009833:0.007100:0.013143:0.009833:0.013181:0.012508:0.012450:0.005711:0.012508:0.013143:0.007466:0.012508:0.009833:0.003848:0.011738:0.009833:0.006523:0.011738:0.012508:0.009833:0.011738:0.012508:0.011699:0.006523:0.005703:0.012604:0.013123:0.011738:0.003848:0.003848:0.005330
granulocyte  count  below 0.5 x 10 /litre) :@0.524249:0.821160:0.920479:0.821192:0.920479:0.805436:0.524249:0.805404:0.012950:0.005792:0.013143:0.011738:0.011699:0.003848:0.012604:0.012450:0.010314:0.006523:0.012508:0.005330:0.005234:0.012450:0.012604:0.011699:0.011738:0.006523:0.005330:0.005240:0.013123:0.012508:0.003848:0.012604:0.015990:0.010583:0.010660:0.005330:0.010660:0.010583:0.009236:0.010583:0.010660:0.010660:0.006198:0.008409:0.003848:0.003848:0.006523:0.005717:0.012508:0.007100:-0.632147
9:@0.860978:0.815573:0.867193:0.815573:0.867193:0.806387:0.860978:0.806387:0.006215
can be improved with G-CSF (granulo-:@0.524238:0.837622:0.915130:0.837622:0.915130:0.821866:0.524238:0.821866:0.012450:0.013143:0.011738:0.011430:0.013123:0.012508:0.011430:0.003848:0.018049:0.013123:0.005717:0.012604:0.010660:0.012508:0.013181:0.011430:0.015990:0.003848:0.006523:0.011738:0.011430:0.016779:0.006388:0.015644:0.009583:0.009333:0.011430:0.007100:0.012950:0.005792:0.013143:0.011738:0.011699:0.003848:0.012604:0.006388
cyte-colony-stimulating  factor,  e.g.,  fil-:@0.524238:0.854053:0.915145:0.854053:0.915145:0.838297:0.524238:0.838297:0.012450:0.010314:0.006523:0.012508:0.006388:0.012450:0.012604:0.003848:0.012604:0.011738:0.010314:0.006388:0.007466:0.006523:0.003848:0.018049:0.011699:0.003848:0.013143:0.006523:0.003848:0.011738:0.012950:0.005330:0.012084:0.006042:0.013143:0.012450:0.006523:0.012604:0.003762:0.005330:0.005330:0.012084:0.012508:0.005330:0.012950:0.005330:0.005330:0.005330:0.012073:0.004686:0.004686:0.003848:0.006388
grastim,  pegfilgrastim).  Immunosuppres-:@0.524238:0.870484:0.915147:0.870484:0.915147:0.854728:0.524238:0.854728:0.012950:0.005792:0.013143:0.007466:0.006523:0.003848:0.018049:0.005330:0.005330:0.010583:0.013123:0.012508:0.012950:0.004686:0.004686:0.003848:0.012950:0.005792:0.013143:0.007466:0.006523:0.003848:0.018049:0.007100:0.005330:0.005330:0.010589:0.004349:0.018049:0.018049:0.011699:0.011738:0.012604:0.007466:0.011699:0.013123:0.013123:0.005709:0.012508:0.007466:0.006388
sion  and  myelosuppression may result  in :@0.524238:0.886914:0.920489:0.886914:0.920489:0.871158:0.524238:0.871158:0.007466:0.003848:0.012604:0.011738:0.005330:0.004320:0.013143:0.011738:0.013181:0.005330:0.004320:0.018049:0.010314:0.012508:0.003848:0.012604:0.007466:0.011699:0.013123:0.013123:0.005719:0.012508:0.007466:0.007466:0.003848:0.012604:0.011738:0.009660:0.018049:0.013143:0.010314:0.009660:0.005713:0.012508:0.007466:0.011699:0.003848:0.006523:0.005330:0.004320:0.003848:0.011738:0.005330
dose reductions and dose delays. These :@0.524238:0.903345:0.920494:0.903345:0.920494:0.887589:0.524238:0.887589:0.013181:0.012604:0.007466:0.012508:0.009082:0.005713:0.012508:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.009082:0.013143:0.011738:0.013181:0.009082:0.013181:0.012604:0.007466:0.012508:0.009082:0.013181:0.012508:0.003848:0.013143:0.010314:0.007466:0.005330:0.009082:0.008197:0.011738:0.012508:0.007466:0.012508:0.005330
dose reductions and delays may compro-:@0.524238:0.919776:0.915151:0.919776:0.915151:0.904020:0.524238:0.904020:0.013181:0.012604:0.007466:0.012508:0.005292:0.005713:0.012508:0.013181:0.011699:0.012450:0.006523:0.003848:0.012604:0.011738:0.007466:0.005292:0.013143:0.011738:0.013181:0.005292:0.013181:0.012508:0.003848:0.013143:0.010314:0.007466:0.005303:0.018049:0.013143:0.010314:0.005292:0.012450:0.012604:0.018049:0.013123:0.005709:0.012604:0.006388
mise cancer-treatment outcome.:@0.524238:0.936206:0.836224:0.936206:0.836224:0.920450:0.524238:0.920450:0.018049:0.003848:0.007466:0.012508:0.005330:0.012450:0.013143:0.011738:0.012450:0.012508:0.005792:0.006388:0.006523:0.005705:0.012508:0.013143:0.006523:0.018049:0.012508:0.011738:0.006523:0.005330:0.012604:0.011699:0.006523:0.012450:0.012604:0.018049:0.012508:0.005330
20-22:@0.836198:0.930625:0.864783:0.930625:0.864783:0.921439:0.836198:0.921439:0.006215:0.006215:0.003724:0.006215:0.006215
Table 4. Common side effects  :@0.524242:0.096166:0.804969:0.096166:0.804969:0.080132:0.524242:0.080132:0.007889:0.012508:0.012508:0.004426:0.012123:0.005195:0.010583:0.005195:0.005195:0.014817:0.012123:0.017895:0.017895:0.012123:0.011353:0.005195:0.008274:0.004426:0.012508:0.012123:0.005195:0.012123:0.005195:0.005195:0.012123:0.012123:0.005580:0.008465:0.004986:0.005388
of chemotherapy:@0.524242:0.112332:0.683569:0.112332:0.683569:0.096298:0.524242:0.096298:0.012123:0.005195:0.005195:0.012123:0.011353:0.012123:0.017895:0.012123:0.005580:0.011353:0.012123:0.005965:0.012508:0.012508:0.011161
Fatigue:@0.533867:0.143087:0.603871:0.143087:0.603871:0.127331:0.533867:0.127331:0.009333:0.013143:0.006523:0.003848:0.012950:0.011699:0.012508
Hair loss:@0.533867:0.165510:0.606507:0.165510:0.606507:0.149754:0.533867:0.149754:0.013143:0.013143:0.003848:0.005792:0.005330:0.003848:0.012604:0.007466:0.007466
Thrombocytopaenia  :@0.533867:0.187934:0.735941:0.187934:0.735941:0.172178:0.533867:0.172178:0.008197:0.011738:0.005705:0.012604:0.018049:0.013123:0.012604:0.012450:0.010314:0.006523:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.005330
(easy bruising and bleeding):@0.533867:0.204100:0.799720:0.204100:0.799720:0.188344:0.533867:0.188344:0.007100:0.012508:0.013143:0.007466:0.010314:0.005330:0.013123:0.005792:0.011699:0.003848:0.007466:0.003848:0.011738:0.012950:0.005330:0.013143:0.011738:0.013181:0.005330:0.013123:0.003848:0.012508:0.012508:0.013181:0.003848:0.011738:0.012950:0.007100
Neutropaenia and infection:@0.533867:0.226523:0.794665:0.226523:0.794665:0.210767:0.533867:0.210767:0.014239:0.012508:0.011699:0.006523:0.005702:0.012604:0.013123:0.013143:0.012508:0.011738:0.003848:0.013143:0.005330:0.013143:0.011738:0.013181:0.005330:0.003848:0.011738:0.006042:0.012508:0.012450:0.006523:0.003848:0.012604:0.011738
Anaemia (low red-blood-cell counts):@0.533867:0.248947:0.877839:0.248947:0.877839:0.233191:0.533867:0.233191:0.014239:0.011738:0.013143:0.012508:0.018049:0.003848:0.013143:0.005330:0.007100:0.003848:0.012604:0.015990:0.005330:0.005709:0.012508:0.013181:0.006388:0.013123:0.003848:0.012604:0.012604:0.013181:0.006388:0.012450:0.012508:0.003848:0.003848:0.005330:0.012450:0.012604:0.011699:0.011738:0.006523:0.007466:0.007100
Septicaemia:@0.533867:0.271370:0.652593:0.271370:0.652593:0.255614:0.533867:0.255614:0.009583:0.012508:0.013123:0.006523:0.003848:0.012450:0.013143:0.012508:0.018049:0.003848:0.013143
Chemotherapy-induced nausea and :@0.533867:0.293794:0.886292:0.293794:0.886292:0.278038:0.533867:0.278038:0.015644:0.011738:0.012508:0.018049:0.012604:0.006523:0.011738:0.012508:0.005792:0.013143:0.013123:0.010314:0.006388:0.003848:0.011738:0.013181:0.011699:0.012450:0.012508:0.013181:0.005330:0.011738:0.013143:0.011699:0.007466:0.012508:0.013143:0.005330:0.013143:0.011738:0.013181:0.005330
vomiting (CINV):@0.533867:0.309960:0.681360:0.309960:0.681360:0.294204:0.533867:0.294204:0.010660:0.012604:0.018049:0.003848:0.006523:0.003848:0.011738:0.012950:0.005330:0.007100:0.015644:0.004349:0.014239:0.013508:0.007100
Appetite changes:@0.533867:0.332383:0.703585:0.332383:0.703585:0.316627:0.533867:0.316627:0.014239:0.013123:0.013123:0.012508:0.006523:0.003848:0.006523:0.012508:0.005330:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466
Constipation:@0.533867:0.354807:0.652670:0.354807:0.652670:0.339051:0.533867:0.339051:0.015644:0.012604:0.011738:0.007466:0.006523:0.003848:0.013123:0.013143:0.006523:0.003848:0.012604:0.011738
Diarrhoea:@0.533867:0.377230:0.627305:0.377230:0.627305:0.361474:0.533867:0.361474:0.014316:0.003848:0.013143:0.005792:0.006346:0.011738:0.012604:0.012508:0.013143
Mucositis:@0.533867:0.399653:0.617456:0.399653:0.617456:0.383897:0.533867:0.383897:0.017684:0.011699:0.012450:0.012604:0.007466:0.003848:0.006523:0.003848:0.007466
Neuropathy:@0.533867:0.422077:0.645462:0.422077:0.645462:0.406321:0.533867:0.406321:0.014239:0.012508:0.011699:0.005703:0.012604:0.013123:0.013143:0.006523:0.011738:0.010314
Skin and nail changes :@0.533867:0.444500:0.742647:0.444500:0.742647:0.428744:0.533867:0.428744:0.009583:0.009660:0.003848:0.011738:0.005330:0.013143:0.011738:0.013181:0.005330:0.011738:0.013143:0.003848:0.003848:0.005330:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466:0.005330
Urine and bladder changes and kidney :@0.533867:0.466924:0.906477:0.466924:0.906477:0.451168:0.533867:0.451168:0.012604:0.005792:0.003848:0.011738:0.012508:0.005330:0.013143:0.011738:0.013181:0.005330:0.013123:0.003848:0.013143:0.013181:0.013181:0.012508:0.005792:0.005330:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466:0.005330:0.013143:0.011738:0.013181:0.005330:0.009660:0.003848:0.013181:0.011738:0.012508:0.010314:0.005330
problems:@0.533867:0.483090:0.620304:0.483090:0.620304:0.467334:0.533867:0.467334:0.013123:0.005715:0.012604:0.013123:0.003848:0.012508:0.018049:0.007466
Weight changes:@0.533867:0.505513:0.686327:0.505513:0.686327:0.489757:0.533867:0.489757:0.017570:0.012508:0.003848:0.012950:0.011738:0.006523:0.005330:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466
Chemo brain (can affect :@0.533867:0.527937:0.774557:0.527937:0.774557:0.512181:0.533867:0.512181:0.015644:0.011738:0.012508:0.018049:0.012604:0.005330:0.013123:0.005792:0.013143:0.003848:0.011738:0.005330:0.007100:0.012450:0.013143:0.011738:0.005330:0.013143:0.006086:0.006042:0.012508:0.012450:0.006523:0.005330
concentration and focus):@0.533867:0.544103:0.773608:0.544103:0.773608:0.528347:0.533867:0.528347:0.012450:0.012604:0.011738:0.012450:0.012508:0.011738:0.006523:0.005792:0.013143:0.006523:0.003848:0.012604:0.011738:0.005330:0.013143:0.011738:0.013181:0.005330:0.006042:0.012604:0.012450:0.011699:0.007466:0.007100
Mood changes:@0.533867:0.566526:0.677262:0.566526:0.677262:0.550770:0.533867:0.550770:0.017684:0.012604:0.012604:0.013181:0.005330:0.012450:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466
Changes in libido and sexual function:@0.533867:0.588950:0.884348:0.588950:0.884348:0.573194:0.533867:0.573194:0.015644:0.011738:0.013143:0.011738:0.012950:0.012508:0.007466:0.005330:0.003848:0.011738:0.005330:0.003848:0.003848:0.013123:0.003848:0.013181:0.012604:0.005330:0.013143:0.011738:0.013181:0.005330:0.007466:0.012508:0.009236:0.011699:0.013143:0.003848:0.005330:0.006042:0.011699:0.011738:0.012450:0.006523:0.003848:0.012604:0.011738
Fertility problems:@0.533867:0.611373:0.688170:0.611373:0.688170:0.595617:0.533867:0.595617:0.009333:0.012508:0.005792:0.006523:0.003848:0.003848:0.003848:0.006523:0.010314:0.005330:0.013123:0.005713:0.012604:0.013123:0.003848:0.012508:0.018049:0.007466